DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Viread (Tenofovir Disoproxil) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (31)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Viread (Tenofovir Disoproxil) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 31   Next >>

Possible Viread side effects in female

Reported by a physician from France on 2012-08-21

Patient: female

Reactions: Drug Ineffective, Clostridium Difficile Colitis, Neurocryptococcosis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ambisome
    Dosage: unk
    Indication: Neurocryptococcosis
    Start date: 2012-01-01

Viread
    Dosage: 1 df, uid/qd
    Administration route: Oral
    Indication: Hepatitis B
    Start date: 2011-12-12

Prograf
    Dosage: unk
    Administration route: Oral
    Indication: Renal Transplant

Other drugs received by patient: Duragesic-100; Neurontin; Atorvastatin; Prednisone TAB; Baraclude; Cellcept; Morphine Sulfate; Flucytosine; Lasix



Possible Viread side effects in female

Reported by a physician from France on 2012-08-09

Patient: female

Reactions: Drug Ineffective, Clostridium Difficile Colitis, Neurocryptococcosis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Viread
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hepatitis B
    Start date: 2011-12-12

Ambisome
    Indication: Neurocryptococcosis

Prograf
    Dosage: unk
    Administration route: Oral
    Indication: Renal Transplant

Other drugs received by patient: Baraclude; Cellcept / 01275104 /; Duragesic-100; Morphine Sulfate; Neurontin; Prednisone TAB; Atorvastatin; Lasix



Possible Viread side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-02

Patient: male

Reactions: Adverse Event

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread

Videx

Reyataz

Norvir



Possible Viread side effects in female

Reported by a physician from France on 2012-07-18

Patient: female

Reactions: Drug Ineffective, Clostridium Difficile Colitis, Neurocryptococcosis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ambisome
    Indication: Neurocryptococcosis

Viread
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hepatitis B
    Start date: 2011-12-12

Other drugs received by patient: Atorvastatin; Lasix; Baraclude; Prograf; Morphine Sulfate; Neurontin; Cellcept / 01275104 /; Prednisone TAB; Duragesic-100



Possible Viread side effects in female

Reported by a physician from France on 2012-07-11

Patient: female

Reactions: Clostridium Difficile Colitis, Nervous System Disorder, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Viread

Other drugs received by patient: Prograf; Prednisone TAB; Cellcept / 01275104 /; Lasix; Duragesic-100; Atorvastatin; Actiskenan; Baraclude; Neurontin



Possible Viread side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-05

Patient: male

Reactions: Lung Neoplasm Malignant, Blood Glucose Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Viread
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: Hepatitis B
    Start date: 2009-01-01

Viread
    Dosage: unk
    Start date: 2010-05-15



Possible Viread side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-19

Patient: male

Reactions: Lung Neoplasm Malignant, Blood Glucose Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Viread



Possible Viread side effects in male

Reported by a physician from United States on 2012-06-18

Patient: male

Reactions: Acute Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-04-16

Ritonavir
    Dosage: unk
    Indication: HIV Infection
    Start date: 2002-06-06

Elvitegravir
    Dosage: 150 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-04-16

Other drugs received by patient: Clobetasol Propionate; Albuterol; Viagra; Hydrocodone / Acetaminophen / 01554201 /; Prezista



Possible Viread side effects in

Reported by a physician from United States on 2012-06-11

Patient:

Reactions: Hepatic Neoplasm Malignant

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Viread



Possible Viread side effects in male

Reported by a physician from United States on 2012-06-04

Patient: male

Reactions: Acute Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-04-16

Ritonavir
    Dosage: unk
    Indication: HIV Infection
    Start date: 2002-06-06

Elvitegravir
    Dosage: 150 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-04-16

Other drugs received by patient: Albuterol; Clobetasol Propionate; Hydrocodone / Acetaminophen / 01554201 /; Prezista; Viagra



Possible Viread side effects in female

Reported by a physician from France on 2012-05-29

Patient: female

Reactions: Urinary Tract Infection, Pyelonephritis, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread



Possible Viread side effects in female

Reported by a physician from France on 2012-04-26

Patient: female

Reactions: Urinary Tract Infection, Pyelonephritis, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread



Possible Viread side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-02

Patient: 55 year old male, weighing 72.0 kg (158.4 pounds)

Reactions: Coronary Artery Disease

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Viread
    Indication: HIV Infection
    Start date: 2006-10-30

Darunavir Hydrate
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Norvir
    Indication: HIV Infection
    Start date: 2006-10-30

Ziagen
    Indication: HIV Infection
    Start date: 2006-10-30

Other drugs received by patient: Enalapril; Chlorthalidone



Possible Viread side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-02

Patient: female

Reactions: Metabolic Acidosis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Viread



Possible Viread side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-19

Patient: female

Reactions: Metabolic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread



Possible Viread side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-08

Patient: female

Reactions: Metabolic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread



Possible Viread side effects in male

Reported by a physician from Denmark on 2012-03-06

Patient: male

Reactions: Intestinal Ischaemia, Renal Failure, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread
    Dosage: 245 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-05-11
    End date: 2011-10-07

Metformin HCL
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2009-01-01
    End date: 2011-10-07

Other drugs received by patient: Epivir; Amaryl; Simvastatin; Efavirenz; Centyl MED Kaliumklorid; Metoprolol Succinate



Possible Viread side effects in male

Reported by a physician from Denmark on 2012-03-02

Patient: male

Reactions: Intestinal Ischaemia, Renal Failure, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Metformin HCL
    Dosage: 1000 mg, unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2009-01-01
    End date: 2011-10-07

Viread
    Dosage: 245 mg, unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-05-11
    End date: 2011-10-07

Other drugs received by patient: Amaryl; Centyl MED Kaliumklorid; Metoprolol Succinate; Epivir; Simvastatin; Efavirenz



Possible Viread side effects in male

Reported by a physician from Denmark on 2012-02-07

Patient: male

Reactions: Intestinal Ischaemia, Renal Failure, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread
    Dosage: 245 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-05-11
    End date: 2011-10-07

Metformin HCL
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2009-01-01
    End date: 2011-10-07

Other drugs received by patient: Metoprolol Succinate; Centyl MED Kaliumklorid; Epivir; Simvastatin; Efavirenz; Amaryl



Possible Viread side effects in 78 year old male

Reported by a physician from Denmark on 2012-02-07

Patient: 78 year old male

Reactions: Intestinal Ischaemia, Renal Failure, Gastrointestinal Haemorrhage, Dialysis, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread
    Dosage: 245 mg (245 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-05-11
    End date: 2011-10-07

Metformin HCL
    Dosage: 2000 mg (1000 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2009-01-01
    End date: 2011-10-07

Other drugs received by patient: Centyl MED Kaliumklorid (Salures-K); Epivir; Amaryl; Metoprolol Succinate; Efavirenz



Possible Viread side effects in 31 year old male

Reported by a consumer/non-health professional from United States on 2012-02-01

Patient: 31 year old male

Reactions: Liver Function Test Abnormal, Arthritis Bacterial, Hepatic Cirrhosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Efavirenz
    Dosage: therapy start date: 25-apr-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Truvada
    Dosage: tabs; therapy start date: 24-may-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-05-24

Norvir
    Dosage: cap.also norvir soft 100mg 1day on 14jul08-unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28
    End date: 2005-04-24

Lamivudine
    Dosage: 150 mg on 29dec97-24may05 300(1day) mg on 25apr05-23may05.tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-05-23

Viread
    Dosage: tab.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Reyataz
    Dosage: divided dose frequency u.also 300mg per 1d on 28jul04-24may05.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-27

Other drugs received by patient: Rabeprazole Sodium; Cysteine; Glycyrrhizinic Acid; Glycine; Kogenate; Octocog Alpha; Ammonium Glycyrrhizinate



Possible Viread side effects in

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-01-31

Patient:

Reactions: Renal Impairment, Gastrointestinal Disorder, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread
    Indication: HIV Infection

Metformin HCL
    Indication: Type 2 Diabetes Mellitus



Possible Viread side effects in 39 year old male

Reported by a consumer/non-health professional from Japan on 2012-01-27

Patient: 39 year old male

Reactions: Hepatic Cirrhosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: 30jan04-27jul04 400 mg (180days). 28jul04-24apr05 300 mg.cap
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2005-04-24

Epivir
    Dosage: also 300mg on 25apr2005-23may2005.tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-05-23

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Norvir
    Dosage: 28jul04-24apr05: 271 days 14jul08-cont.cap. norvir soft
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28

Viread
    Dosage: tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Other drugs received by patient: NEO-Minophagen C; Kogenate; Antihemophilic Factor (Human)



Possible Viread side effects in 31 year old male

Reported by a physician from United States on 2012-01-27

Patient: 31 year old male

Reactions: Liver Function Test Abnormal, Arthritis Bacterial, Hepatic Cirrhosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Efavirenz
    Dosage: therapy start date: 25-apr-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Reyataz
    Dosage: divided dose frequency u.also 300mg per 1d on 28jul04-24may05.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-27

Viread
    Dosage: tab.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Norvir
    Dosage: cap.also norvir soft 100mg 1day on 14jul08-unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28
    End date: 2005-04-24

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Lamivudine
    Dosage: 150 mg on 29dec97-24may05 300(1day) mg on 25apr05-23may05.tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-05-23

Truvada
    Dosage: tabs; therapy start date: 24-may-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-05-24

Other drugs received by patient: Ammonium Glycyrrhizinate; Kogenate; Octocog Alpha; Rabeprazole Sodium; Glycine; Glycyrrhizinic Acid; Cysteine



Possible Viread side effects in 43 year old female

Reported by a physician from France on 2011-12-30

Patient: 43 year old female, weighing 74.0 kg (162.8 pounds)

Reactions: Jaundice, Hepatic Necrosis, Peritoneal Haematoma, Vomiting, Somnolence, Ascites, Aggression, Hepatitis A

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-04-12
    End date: 2003-07-28

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-04-12
    End date: 2003-07-28

Sustiva
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-04-12
    End date: 2003-07-28

Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-04-12
    End date: 2003-07-28



Possible Viread side effects in 45 year old female

Reported by a physician from France on 2011-12-13

Patient: 45 year old female

Reactions: Weight Decreased, Drug Resistance, Acute Generalised Exanthematous Pustulosis, Generalised Erythema, Castleman's Disease, Pancytopenia, Anaphylactic Shock, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvir
    Indication: HIV Infection
    Start date: 2010-05-28
    End date: 2010-06-01

Sustiva
    Administration route: Oral

Prezista
    Start date: 2010-05-28
    End date: 2010-06-01

Nevirapine

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25
    End date: 2010-06-01

Isentress
    Administration route: Oral
    Start date: 2010-08-17
    End date: 2010-01-01

Viread
    Start date: 2010-05-28
    End date: 2010-06-01

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-08-19

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25
    End date: 2010-06-01

Viread
    Start date: 2010-08-11
    End date: 2010-08-11

Other drugs received by patient: Piascledine



Possible Viread side effects in 45 year old female

Reported by a physician from France on 2011-11-23

Patient: 45 year old female

Reactions: Weight Decreased, Drug Resistance, Generalised Erythema, Acute Generalised Exanthematous Pustulosis, Castleman's Disease, Anaphylactic Shock, Pancytopenia, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvir
    Indication: HIV Infection
    Start date: 2010-05-28
    End date: 2010-06-01

Viread
    Start date: 2010-08-11
    End date: 2010-08-11

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25
    End date: 2010-06-01

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25
    End date: 2010-06-01

Prezista
    Start date: 2010-05-28
    End date: 2010-06-01

Isentress
    Administration route: Oral
    Start date: 2010-08-17
    End date: 2010-01-01

Sustiva
    Administration route: Oral

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-08-19

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25

Viread
    Start date: 2010-05-28
    End date: 2010-06-01

Nevirapine

Other drugs received by patient: Piascledine



Possible Viread side effects in 45 year old female

Reported by a consumer/non-health professional from France on 2011-11-20

Patient: 45 year old female

Reactions: Weight Decreased, Acute Generalised Exanthematous Pustulosis, Drug Resistance, Castleman's Disease, Pancytopenia, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: reintroduced on 19aug10
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-08-19

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25

Prezista

Isentress
    Dosage: reintroduced 17aug10,isentress 400mg film-coated tablet.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25

Efavirenz

Viread
    Start date: 2010-08-11

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-25

Norvir
    Indication: HIV Infection
    Start date: 2010-05-28

Other drugs received by patient: Piascledine



Possible Viread side effects in male

Reported by a physician from Denmark on 2011-11-02

Patient: male

Reactions: Intestinal Ischaemia, Renal Failure, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Metformin HCL
    Dosage: 1000 mg, unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    End date: 2011-10-07

Viread
    Dosage: 245 mg, unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-05-11
    End date: 2011-10-07

Other drugs received by patient: Centyl MED Kaliumklorid; Epivir; Efavirenz; Metoprolol Succinate; Amaryl; Simvastatin



Possible Viread side effects in 78 year old male

Reported by a physician from Denmark on 2011-11-01

Patient: 78 year old male

Reactions: Intestinal Ischaemia, Renal Failure, Dialysis, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Metformin HCL
    Dosage: 2000 mg (1000 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Diabetes Mellitus
    End date: 2011-10-07

Viread
    Dosage: 245 mg 9245 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-05-11
    End date: 2011-10-07

Other drugs received by patient: Amaryl; Metoprolol Succinate; Efavirenz; Centyl MED Kaliumklorid (Salures-K); Epivir



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014